Virtus ETF Advisers’s Kronos Bio KRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,844
Closed -$86K 458
2022
Q1
$86K Sell
11,844
-704
-6% -$6K 0.04% 327
2021
Q4
$171K Buy
12,548
+4,422
+54% +$69.2K 0.06% 280
2021
Q3
$170K Sell
8,126
-428
-5% -$9.19K 0.07% 309
2021
Q2
$205K Buy
+8,554
New +$217K 0.08% 327

Other funds holding KRON

Virtus ETF Advisers's KRON Position: Q2 2022 in Review

Virtus ETF Advisers sold out of Kronos Bio (KRON) in Q2 2022, closing a stake of 11,844 shares — an estimated $86K sold.

Virtus ETF Advisers first reported a position in KRON in Q2 2021 and held it in 4 quarters. The position peaked at $205K in Q2 2021. 93 funds tracked by Wall St. Rank hold KRON as of Q2 2022.

  • Virtus ETF Advisers reported no remaining Kronos Bio position as of Q2 2022 after selling out during the quarter.
  • Virtus ETF Advisers sold 11,844 Kronos Bio shares in Q2 2022, an estimated $86K.
  • Virtus ETF Advisers first reported a position in Kronos Bio in Q2 2021 and held it in 4 quarters.
  • Virtus ETF Advisers's Kronos Bio position peaked at $205K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2022.

Based on Virtus ETF Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.